Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD80 anticorps

CD80 Reactivité: Souris FACS Hôte: Rat Monoclonal 1G10-B7 unconjugated
N° du produit ABIN2689409
  • Antigène Voir toutes CD80 Anticorps
    CD80
    Reactivité
    • 138
    • 108
    • 44
    • 8
    • 3
    • 3
    • 1
    • 1
    • 1
    Souris
    Hôte
    • 87
    • 71
    • 23
    • 18
    • 17
    • 1
    • 1
    Rat
    Clonalité
    • 138
    • 77
    • 2
    Monoclonal
    Conjugué
    • 86
    • 18
    • 17
    • 15
    • 13
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CD80 est non-conjugé
    Application
    • 128
    • 93
    • 69
    • 35
    • 34
    • 22
    • 14
    • 13
    • 13
    • 13
    • 11
    • 11
    • 10
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS)
    Marque
    BD Pharmingen™
    Attributs du produit
    The 1G10 antibody reacts with CD80 (B7-1). This member of the Ig superfamily, along with CD86 (B7-2), participates in T-cell costimulation via interactions with CD28 and CD152 (CTLA-4). CD80 is constitutively expressed on dendritic cells, monocytes, and peritoneal macrophages, and it is inducible on B cells by various means, including activation by LPS, IL-4, and the cross-linking of surface Ig. Expression of CD80 is greatly enhanced on splenic B cells following activation by LPS, with peak expression occurring between 48 and 72 hours. It has been reported that activation of purified B cells with LPS can induce CD80 expression in as few as 18 hours. The 1G10 antibody blocks binding of CTLA-4-Ig to CD80, but it does not block stimulation of T cells by natural antigen-presenting cells. Preliminary evidence has shown that mAb 16-10A1 (Cat. no. 553766) blocks binding of 1G10 mAb to CD80, indicating that the two antibodies may recognize overlapping epitopes on the CD80 Molecule. However, the 16-10A1 mAb recognizes an upregulated antigen on UV-irradiated P815 mastocytoma cells which is not detected by the 1G10 mAb, the cause and significance of this differential reactivity of the two anti-CD80 antibodies is unknown. Expression of membrane CD80 (B7-1) by mouse splenocytes. Freshly isolated (left) or 72-hour LPS-stimulated BALB/c splenocytes (right) were stained with purified 1G10/B7 mAb (open histograms) or no primary mAb (shaded histograms). Staining was detected with biotinylated goat anti-rat Ig (Cat. No. 554014) followed by Streptavidin-PE (Cat. No. 554061). Viable resting lymphocytes (left) and blasts (right) were selected by scatter profile and dye exclusion (BD Pharmingen™ Via-Probe™, Cat. No. 555816/555815). Flow cytometry was performed on a FACScan™ .

    BD Pharmingen™ Purified Rat Anti-Mouse CD80 - Purified - Clone 1G10/B7 - Isotype Rat IgG2a, κ - Reactivity Ms - 0.5 mg
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Activated Mouse 5C2 Cells
    Clone
    1G10-B7
    Isotype
    IgG2a kappa
    Top Product
    Discover our top product CD80 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Aqueous buffered solution containing ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Stockage commentaire
    Store undiluted at 4°C.
  • Sojka, Donepudi, Bluestone, Mokyr: "Melphalan and other anticancer modalities up-regulate B7-1 gene expression in tumor cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 164, Issue 12, pp. 6230-6, (2000) (PubMed).

    Bluestone: "New perspectives of CD28-B7-mediated T cell costimulation." dans: Immunity, Vol. 2, Issue 6, pp. 555-9, (1995) (PubMed).

    Boussiotis, Gribben, Freeman, Nadler: "Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance." dans: Current opinion in immunology, Vol. 6, Issue 5, pp. 797-807, (1995) (PubMed).

    Hathcock, Laszlo, Pucillo, Linsley, Hodes: "Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function." dans: The Journal of experimental medicine, Vol. 180, Issue 2, pp. 631-40, (1994) (PubMed).

    Nabavi, Freeman, Gault, Godfrey, Nadler, Glimcher: "Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression." dans: Nature, Vol. 360, Issue 6401, pp. 266-8, (1992) (PubMed).

  • Antigène
    CD80
    Autre désignation
    CD80 (CD80 Produits)
    Synonymes
    anticorps B7, anticorps B7-1, anticorps B7.1, anticorps BB1, anticorps CD28LG, anticorps CD28LG1, anticorps LAB7, anticorps B71, anticorps Cd28l, anticorps Ly-53, anticorps Ly53, anticorps MIC17, anticorps TSA1, anticorps CD80 molecule, anticorps Cd80 molecule, anticorps CD80 antigen, anticorps CD80, anticorps Cd80
    Sujet
    Synonyms: B7-1
    Pathways
    TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Support technique